TGFB1 and neoplasm: Inactivating CAFs by inhibition of TGFβ in vivo also reduces collagen deposition, induces cell-mediated immune response with high expression of Th1 cytokines and chemokines CXCL9 and CXCL10, the recruitment of CD4+, CD8+ T-cells, and M1 macrophages to the tumor area [538].